Understand how corruption affects health outcomes in developing countries. Find essential resources for anyone working on anti-corruption within the sector.
Corruption in the health sector is a concern in all countries, but it is especially critical in developing and transitional economies where public resources are already scarce. Corruption reduces resources available for health, lowers the quality, equity and effectiveness of health care services, decreases the volume and increases the cost of services provided. It discourages people to use and pay for services and ultimately has a corrosive impact on the population's level of health.
Explore this U4 Theme Page to learn about the challenges and strategies that can be employed to address the problem:
New U4 Publication
U4 Issue 2013:3 by J.C. Kohler and N. Ovtcharenko. 26p
Select global initiatives in the area of good governance and medicines have been particularly useful in generating a political and policy dialogue around the issue of pharmaceutical system good governance. The initiatives examined in this paper have been taken by the World Bank, the WHO and the Global Fund, as well as the Medicines Transparency Alliance. The main findings include that these initiatives identify weaknesses in the pharmaceutical system and can provide important baseline data. Recommendations include the need for political analysis, monitoring and evaluation, and the streamlining and uniformity of assessment tools across institutions.